| scholarly article | Q13442814 |
| P50 | author | Judith S Hochman | Q39730635 |
| Deepak L. Bhatt | Q47264894 | ||
| Charles V Pollack | Q59566010 | ||
| William E Boden | Q60503412 | ||
| Erik Magnus Ohman | Q60697402 | ||
| Robert A Harrington | Q62914910 | ||
| Eric D. Peterson | Q63021326 | ||
| Matthew T Roe | Q64684757 | ||
| Sidney C Smith | Q82174061 | ||
| William Peacock | Q88008306 | ||
| Christopher P Cannon | Q90608635 | ||
| Neal S. Kleiman | Q112157008 | ||
| W Brian Gibler | Q114292228 | ||
| Ralph G Brindis | Q114335787 | ||
| CRUSADE Investigators | Q114426404 | ||
| P2093 | author name string | Yun Li | |
| C Michael Gibson | |||
| Peter B Berger | |||
| David J Cohen | |||
| Anita Y Chen | |||
| Adam B Greenbaum | |||
| Jorge F Saucedo | |||
| P433 | issue | 17 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | patient | Q181600 |
| acute coronary syndrome | Q266018 | ||
| P1104 | number of pages | 9 | |
| P304 | page(s) | 2096-2104 | |
| P577 | publication date | 2004-11-01 | |
| P1433 | published in | The Journal of the American Medical Association | Q1470970 |
| P1476 | title | Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative | |
| P478 | volume | 292 |
| Q22241922 | 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines |
| Q37681427 | Acute coronary syndrome in Australia: Where are we now and where are we going? |
| Q37659186 | Acute coronary syndrome in the Middle East: The importance of registries for quality assessment and plans for improvement |
| Q37789014 | Acute coronary syndrome update for hospitalists |
| Q36178899 | Acute coronary syndromes in black Americans: is treatment different? Should it be? |
| Q37638627 | Acute coronary syndromes: selective vs early invasive strategies |
| Q54069247 | Acute myocardial infarction |
| Q36007741 | Adherence to Cardiac Practice Guidelines in the Management of Non-ST-Elevation Acute Coronary Syndromes: A Systematic Literature Review |
| Q34479093 | Age- and sex-specific in-hospital mortality after myocardial infarction in routine clinical practice |
| Q53254097 | Anticoagulation in women with non-valvular atrial fibrillation in the stroke prevention using an oral thrombin inhibitor (SPORTIF) trials. |
| Q36892804 | Antiplatelet therapy in patients with unstable angina and non-ST-segment-elevation myocardial infarction: findings from the CRUSADE national quality improvement initiative |
| Q37797795 | Antithrombotic therapy in patients with diabetes mellitus and coronary artery disease. |
| Q35710639 | Applying propensity score methods in medical research: pitfalls and prospects |
| Q36142053 | Association of chronic renal insufficiency with in-hospital outcomes after percutaneous coronary intervention |
| Q33752850 | Association of prior coronary artery bypass graft surgery with quality of care of patients with non-ST-segment elevation myocardial infarction: a report from the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcome |
| Q37156100 | Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines) Bleeding Score |
| Q57237989 | Bloqueo auriculoventricular en la angina inestable. Resultados del registro ARIAM |
| Q58136282 | Can magnetocardiography detect patients with non‐ST‐segment elevation myocardial infarction? |
| Q36732190 | Cardiologists' and emergency physicians' perspectives on and knowledge of reperfusion guidelines pertaining to ST-segment-elevation myocardial infarction |
| Q46499643 | Cardiovascular disease in the Eastern Mediterranean region: epidemiology and risk factor burden. |
| Q34683098 | Changes in glycoprotein IIb/IIIa inhibitor excess dosing with site-specific safety feedback in the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines (CRUSADE) init |
| Q55381292 | Chronic obstructive pulmonary disease and acute myocardial infarction: effects on presentation, management, and outcomes. |
| Q35741975 | Clinical characteristics, cardiac events and coronary angiographic findings in the prospective PREVEND cohort: an observational study |
| Q47977841 | Clinical epidemiology, management and outcome of acute coronary syndromes in the Italian network on acute coronary syndromes (IN-ACS Outcome study). |
| Q38248586 | Comparative care and outcomes for acute coronary syndromes in Central and Eastern European Transitional countries: A review of the literature |
| Q58375735 | Congestive heart failure complicating non-ST segment elevation acute coronary syndrome: incidence, predictors, and clinical outcomes |
| Q38688312 | Cross-level interaction between individual socioeconomic status and regional deprivation on overall survival after onset of ischemic stroke: National health insurance cohort sample data from 2002 to 2013. |
| Q39805493 | Current management of acute coronary syndromes in Australia: observations from the acute coronary syndromes prospective audit. |
| Q34506171 | Determinants of cardiac catheterization use in older Medicare patients with acute myocardial infarction |
| Q42855772 | Diagnosis of myocardial infarction using the new universal definition: is it enough for risk stratification and guiding decision for revascularization? |
| Q44433455 | Differential prognostic effect of revascularization according to a simple comorbidity index in high-risk non-ST-segment elevation acute coronary syndrome. |
| Q48626444 | Early invasive treatment for acute coronary syndrome in patients with chronic kidney disease: do we know what we're doing? |
| Q44823803 | Early invasive versus selectively invasive strategy in patients with non-ST-segment elevation acute coronary syndrome: impact of age. |
| Q48198112 | Early versus delayed invasive strategy for intermediate- and high-risk acute coronary syndromes managed without P2Y12 receptor inhibitor pretreatment: Design and rationale of the EARLY randomized trial. |
| Q37030849 | Economic evaluation of the use of enoxaparin in non-ST-elevation acute coronary syndrome |
| Q40116416 | Editor's Choice-Medically managed patients with non-ST-elevation acute myocardial infarction have heterogeneous outcomes, based on performance of angiography and extent of coronary artery disease. |
| Q45902457 | Effect of invasive treatment on prognosis in non-ST-segment elevation acute coronary syndrome with or without systolic dysfunction. |
| Q36405303 | Electrocardiographic changes in acute coronary syndromes |
| Q48909740 | Elevated serum cardiac markers predict coronary artery disease in patients with a history of heart failure who present with chest pain: insights from the i*trACS registry |
| Q28213718 | Enoxaparin injection for the treatment of high-risk patients with non-ST elevation acute coronary syndrome |
| Q81214093 | Eptifibatide: a review of its use in patients with acute coronary syndromes and/or undergoing percutaneous coronary intervention |
| Q33430032 | Ethical issues in using data from quality management programs |
| Q85121908 | Evaluation of a selective strategy for glycoprotein IIb/IIIa inhibitors administration in non-ST segment elevation acute coronary syndromes |
| Q37070772 | Evolution of anticoagulant and antiplatelet therapy: benefits and risks of contemporary pharmacologic agents and their implications for myonecrosis and bleeding in percutaneous coronary intervention. |
| Q37148386 | Expanding the recognition and assessment of bleeding events associated with antiplatelet therapy in primary care |
| Q37453028 | Explicit risk in acute coronary syndrome management |
| Q36925442 | External adjustment sensitivity analysis for unmeasured confounding: an application to coronary stent outcomes, Pennsylvania 2004-2008. |
| Q58123845 | Fifteen-Year Trends in Management and Outcomes of Non-ST-Segment-Elevation Myocardial Infarction Among Black and White Patients: The ARIC Community Surveillance Study, 2000-2014 |
| Q44216414 | Frequency of coronary angiography and revascularization among men and women with myocardial infarction and their relationship to mortality at one year: an analysis of the Geisinger myocardial infarction cohort |
| Q46071299 | Frequency of non-ST-segment elevation injury patterns on prehospital electrocardiograms |
| Q37240904 | Gender differences in clinical presentation and management of patients with acute coronary syndrome in Southwest of Saudi Arabia |
| Q36057128 | Gender differences in management and outcomes in patients with acute coronary syndromes: results on 20,290 patients from the AMIS Plus Registry |
| Q28221456 | Gender-related differences in the management of non-ST-elevation acute coronary syndrome patients |
| Q37291908 | Gender-related mortality trends among diabetic patients with ST-segment elevation myocardial infarction: insights from a nationwide registry 1997-2010 |
| Q45206757 | Geographic differences in outcomes in outpatients with established atherothrombotic disease: results from the REACH Registry |
| Q38328950 | Health resource variability in the achievement of optimal performance and clinical outcome in ischemic heart disease |
| Q40230894 | High adherence to therapy and low cardiac mortality and morbidity in patients after acute coronary syndrome systematically managed by office-based cardiologists in Germany: 1-year outcomes of the ProAcor Study |
| Q36022248 | Impact of an Early Invasive Strategy versus Conservative Strategy for Unstable Angina and Non-ST Elevation Acute Coronary Syndrome in Patients with Chronic Kidney Disease: A Systematic Review |
| Q55379923 | Improved short and long term survival associated with percutaneous coronary intervention in the elderly patients with acute coronary syndrome. |
| Q41232859 | In-hospital management and outcomes of acute coronary syndromes in relation to prior history of heart failure. |
| Q44560156 | In-hospital outcomes of very elderly patients (85 years and older) undergoing percutaneous coronary intervention |
| Q37481596 | Indications, algorithms, and outcomes for coronary artery bypass surgery in patients with acute coronary syndromes |
| Q34748390 | Influence of comorbid conditions on one-year outcomes in non-ST-segment elevation acute coronary syndrome |
| Q84395828 | Integrated SPECT/CT for assessment of haemodynamically significant coronary artery lesions in patients with acute coronary syndrome |
| Q35773204 | Intervention in acute coronary syndromes: do patients undergo intervention on the basis of their risk characteristics? The Global Registry of Acute Coronary Events (GRACE) |
| Q37544856 | Interventions for cardiovascular disease in women |
| Q34283808 | Is there attenuation of benefit of invasive therapy in patients with chronic kidney disease? Results from randomized trials and registry data |
| Q93646466 | JournalScan |
| Q94703862 | Lessons learned from the CRUSADE National Quality Improvement Initiative |
| Q38577755 | Long-term dual antiplatelet therapy for secondary prevention of cardiovascular events in the subgroup of patients with previous myocardial infarction: a collaborative meta-analysis of randomized trials |
| Q36801418 | Long-term prognosis of patients with acute non-ST-segment elevation myocardial infarction undergoing different treatment strategies |
| Q28196868 | Magnitude and consequences of undertreatment of high-risk patients with non-ST segment elevation acute coronary syndromes: insights from the DESCARTES Registry |
| Q28193674 | Medications for the treatment of acute coronary syndromes |
| Q39789998 | Mortality of patients with acute coronary syndromes still remains high: a follow-up study of 1188 consecutive patients admitted to a university hospital. |
| Q53141587 | Mortality trends for non-ST-segment elevation myocardial infarction (NSTEMI) in the United States from 1988 to 2004. |
| Q46328333 | Multicentre evaluation of a new point-of-care test for the determination of CK-MB in whole blood |
| Q36519924 | Non ST segment elevation acute coronary syndromes: A simplified risk-orientated algorithm |
| Q35026325 | Non-ST-elevation myocardial infarction in the United States: contemporary trends in incidence, utilization of the early invasive strategy, and in-hospital outcomes |
| Q38023208 | Nurses' role in the acute management of patients with non-ST-segment elevation acute coronary syndromes: an integrative review |
| Q42818373 | Observational study of adherence to European clinical practice guidelines for the management of acute coronary syndrome in revascularized versus non-revascularized patients – the CONNECT Study |
| Q28218094 | Optimizing platelet P2Y12 inhibition for patients undergoing PCI |
| Q38817125 | Optimizing the Use of Cangrelor in the Real World |
| Q41101718 | Outcomes of Women and Men With Acute Coronary Syndrome Treated With and Without Percutaneous Coronary Revascularization |
| Q37119085 | Paradoxical use of invasive cardiac procedures for patients with non-ST segment elevation myocardial infarction: an international perspective from the CRUSADE Initiative and the Canadian ACS Registries I and II. |
| Q37396789 | Patient and hospital characteristics associated with inappropriate percutaneous coronary interventions |
| Q36577316 | Patient and hospital determinants of primary percutaneous coronary intervention in England, 2003-2013 |
| Q80146662 | Pay for performance in myocardial infarction: are we reaping the rewards? |
| Q33955828 | Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting: Intervention in Older Persons with Acute Coronary Syndrome-Part II. |
| Q35138249 | Percutaneous coronary intervention in elderly patients: is it beneficial? |
| Q82791112 | Percutaneous coronary intervention in the elderly |
| Q36404529 | Persistence of evidence-based medication use after discharge from academic versus nonacademic hospitals among patients with non-ST-segment elevation myocardial infarction |
| Q57252716 | Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trial |
| Q35714397 | Precision medicine to improve use of bleeding avoidance strategies and reduce bleeding in patients undergoing percutaneous coronary intervention: prospective cohort study before and after implementation of personalized bleeding risks |
| Q28596228 | Predicting mortality after acute coronary syndromes in people with chronic obstructive pulmonary disease |
| Q51485110 | Predictive value of admission hyperglycaemia on mortality in patients with acute myocardial infarction. |
| Q42339379 | Predictors of Mortality in Elderly Patients with Non-ST Elevation Acute Coronary Syndrome - Data from Taiwan Acute Coronary Syndrome Full Spectrum Registry |
| Q44445340 | Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromes |
| Q35310950 | Prognosis following acute coronary syndromes according to prior coronary artery bypass grafting: Meta-analysis |
| Q57764402 | Prognostic implications of early and long-term bleeding events in patients on one-year dual antiplatelet therapy following drug-eluting stent implantation |
| Q57235883 | Pronóstico y manejo de los pacientes con síndrome coronario agudo y enfermedad polivascular |
| Q47440122 | Quality of care and outcomes among patients with acute myocardial infarction by level of kidney function at admission: report from the get with the guidelines coronary artery disease program. |
| Q43109030 | Radial first: paradox+proficiency=opportunity |
| Q92562261 | Reinforcement of patient education improved physicians' adherence to guideline-recommended medical therapy after acute coronary syndrome |
| Q36984658 | Renal outcomes associated with invasive versus conservative management of acute coronary syndrome: propensity matched cohort study |
| Q47440040 | Reperfusion strategies and quality of care in 5339 patients age 80 years or older presenting with ST-elevation myocardial infarction: analysis from get with the guidelines-coronary artery disease |
| Q37229031 | Risk Factors and Event Rates in Patients With Atherothrombotic Disease in Germany: Results of the REACH Registry |
| Q38835473 | Risk Scores After Acute Coronary Syndrome |
| Q64086439 | Risk factors for repeat percutaneous coronary intervention in young patients (≤45 years of age) with acute coronary syndrome |
| Q37951403 | Routine invasive versus conservative management in non-ST-elevation acute coronary syndromes. |
| Q38832085 | Routine invasive versus selective invasive strategies for Non-ST-elevation acute coronary syndromes: An Updated meta-analysis of randomized trials |
| Q47098496 | ST segment change and T wave amplitude ratio in lead aVR associated with coronary artery disease severity in patients with non-ST elevation myocardial infarction: A retrospective study. |
| Q38097508 | Selection and timing for invasive therapy in non-ST-segment-elevation acute coronary syndrome. |
| Q35108013 | Six-month mortality and cardiac catheterization in non-ST-segment elevation myocardial infarction patients with anemia |
| Q82620398 | Survival and changes in physical ability after coronary revascularization for octa-nonagenerian patients with acute coronary syndrome |
| Q52664996 | Sustained Sex-based Treatment Differences in Acute Coronary Syndrome Care: Insights from the American Heart Association Get With the Guidelines Coronary Artery Disease Registry. |
| Q37445883 | Target populations and relevant therapeutic end points to further improve outcomes in NSTEACS patients |
| Q51852604 | Temporal management patterns and outcomes of non-ST elevation acute coronary syndromes in patients with kidney dysfunction. |
| Q61446637 | Temporal trends and inequalities in coronary angiography utilization in the management of non-ST-Elevation acute coronary syndromes in the U.S |
| Q37419434 | Temporal trends in the use of invasive cardiac procedures for non-ST segment elevation acute coronary syndromes according to initial risk stratification |
| Q36162429 | The association of in-hospital major bleeding with short-, intermediate-, and long-term mortality among older patients with non-ST-segment elevation myocardial infarction |
| Q80275766 | The early invasive strategy revisited: FRISC II at 5 years |
| Q34502915 | The effect of a regional care model on cardiac catheterization rates in patients with Acute Coronary Syndromes |
| Q36009093 | The impact of COPD on management and outcomes of patients hospitalized with acute myocardial infarction: a 10-year retrospective observational study |
| Q35765059 | The impact of increased age on outcome from a strategy of early invasive management and revascularisation in patients with acute coronary syndromes: retrospective analysis study from the ACACIA registry |
| Q37248944 | The role of invasive therapies in elderly patients with acute myocardial infarction. |
| Q84804663 | Treatment Strategies and Risk Stratification in Acute Coronary Syndrome: How Do We Identify Patients Who Would Benefit From Early Invasive Treatment? |
| Q36369711 | Treatment of non-ST-elevation acute coronary syndrome in the elderly: current practice and future opportunities |
| Q37328685 | Trends from 1996 to 2007 in incidence and mortality outcomes of heart failure after acute myocardial infarction: a population-based study of 20,812 patients with first acute myocardial infarction in Western Australia |
| Q36233107 | Troponin and Cardiac Events in Stable Ischemic Heart Disease and Diabetes |
| Q30607483 | Understanding factors that influence the use of risk scoring instruments in the management of patients with unstable angina or non-ST-elevation myocardial infarction in the Netherlands: a qualitative study of health care practitioners' perceptions |
| Q33876187 | Use of platelet glycoprotein IIb/IIIa inhibitors in diabetics undergoing PCI for non-ST-segment elevation acute coronary syndromes: impact of clinical status and procedural characteristics |
| Q43683593 | Utilization and determinants of in-hospital cardiac catheterization in patients with acute coronary syndrome from the Middle East. |
| Q43643460 | Validation of the GRACE risk score for predicting death within 6 months of follow-up in a contemporary cohort of patients with acute coronary syndrome |
| Q37387764 | Validation of the GRACE score for prognosis in Indian patients with acute coronary syndromes |
| Q51748555 | Vorapaxar, a platelet thrombin-receptor antagonist, in medically managed patients with non-ST-segment elevation acute coronary syndrome: results from the TRACER trial. |
| Q83956838 | [Clinical pathway "Acute Coronary Syndrome"] |
| Q80203988 | [The CRUSADE study, evaluation model of quality in percutaneous coronary intervention] |
| Q26829973 | 2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Associat |
| Q26774798 | 2015 ACR/ACC/AHA/AATS/ACEP/ASNC/NASCI/SAEM/SCCT/SCMR/SCPC/SNMMI/STR/STS Appropriate Utilization of Cardiovascular Imaging in Emergency Department Patients With Chest Pain: A Joint Document of the American College of Radiology Appropriateness Criteri |
Search more.